Evaluation of an Interprofessional Academic-Practice Partnership in End of Life Care.

Innovations in Pharmacy Pub Date : 2021-09-22 eCollection Date: 2021-01-01 DOI:10.24926/iip.v12i4.4004
Katie F Leslie, M Kate Probst, Taylor L Hawkins
{"title":"Evaluation of an Interprofessional Academic-Practice Partnership in End of Life Care.","authors":"Katie F Leslie, M Kate Probst, Taylor L Hawkins","doi":"10.24926/iip.v12i4.4004","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> The purpose of this mixed-methods study was to evaluate an interprofessional academic-practice partnership in end of life care by examining patient medication outcomes, the contributions of student pharmacists and a pharmacy preceptor to care teams, and student learning experiences. <b>Methods:</b> Retrospective chart review assessed polypharmacy differences in hospice patients with a primary terminal diagnosis of non-Alzheimer's dementia between two patient groups; Group 1 managed on interprofessional care teams within the pharmacy partnership, and Group 2, managed on teams without a pharmacist. Team members who interacted with student pharmacists and the pharmacy preceptor participated in semi-structured key informant interviews to document perceptions of pharmacy contributions to care teams and the organization. At the end of their APPE, students completed reflective writings regarding their learning. <b>Results:</b> Patients in Group 1 were on statistically significant fewer medications than Group 2 at both week 4 and weeks 7-12 following admission. Five conceptual themes emerged from interviews: pharmacists as team medication experts, improved patient outcomes, interprofessional collaboration, patient/caregiver trust in medication regimens, and desire for sustainability. Student reflections included the following learning themes: teamwork, respect, value, and patient-centered care. <b>Conclusions:</b> The addition of a pharmacist on interprofessional care teams decreased the average number of medications in the non-Alzheimer's end of life patient population. Team members identified value-added contributions of student pharmacists and the pharmacy preceptor that enhanced team efficiency and patient care. Student pharmacists recognized these contributions and the experience served as an exemplar of interprofessional practice.</p>","PeriodicalId":13646,"journal":{"name":"Innovations in Pharmacy","volume":"12 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/88/21550417-12-04-4004.PMC9401366.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovations in Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24926/iip.v12i4.4004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The purpose of this mixed-methods study was to evaluate an interprofessional academic-practice partnership in end of life care by examining patient medication outcomes, the contributions of student pharmacists and a pharmacy preceptor to care teams, and student learning experiences. Methods: Retrospective chart review assessed polypharmacy differences in hospice patients with a primary terminal diagnosis of non-Alzheimer's dementia between two patient groups; Group 1 managed on interprofessional care teams within the pharmacy partnership, and Group 2, managed on teams without a pharmacist. Team members who interacted with student pharmacists and the pharmacy preceptor participated in semi-structured key informant interviews to document perceptions of pharmacy contributions to care teams and the organization. At the end of their APPE, students completed reflective writings regarding their learning. Results: Patients in Group 1 were on statistically significant fewer medications than Group 2 at both week 4 and weeks 7-12 following admission. Five conceptual themes emerged from interviews: pharmacists as team medication experts, improved patient outcomes, interprofessional collaboration, patient/caregiver trust in medication regimens, and desire for sustainability. Student reflections included the following learning themes: teamwork, respect, value, and patient-centered care. Conclusions: The addition of a pharmacist on interprofessional care teams decreased the average number of medications in the non-Alzheimer's end of life patient population. Team members identified value-added contributions of student pharmacists and the pharmacy preceptor that enhanced team efficiency and patient care. Student pharmacists recognized these contributions and the experience served as an exemplar of interprofessional practice.

Abstract Image

临终关怀中跨专业学术与实践伙伴关系的评估。
引言:这项混合方法研究的目的是通过检查患者的药物治疗结果、学生药剂师和药学导师对护理团队的贡献以及学生的学习经历,来评估临终关怀中的跨专业学术实践伙伴关系。方法:回顾性图表回顾评估了两组患者中以非阿尔茨海默氏痴呆为主要终末期诊断的临终关怀患者的多药治疗差异;第1组由药房合作伙伴关系内的跨专业护理团队管理,第2组由没有药剂师的团队管理。与学生药剂师和药学导师互动的团队成员参加了半结构化的关键信息员访谈,以记录对护理团队和组织的药学贡献的看法。在APPE结束时,学生们完成了关于他们学习的反思性写作。结果:在入院后第4周和第7-12周,第1组患者服用的药物比第2组少,具有统计学意义。访谈中出现了五个概念主题:药剂师作为团队药物专家,改善患者结果,跨专业合作,患者/护理人员对药物方案的信任,以及对可持续性的渴望。学生的反思包括以下学习主题:团队合作、尊重、价值观和以患者为中心的护理。结论:在跨专业护理团队中增加一名药剂师,降低了非阿尔茨海默氏症临终患者群体的平均药物数量。团队成员确定了学生药剂师和药学导师的增值贡献,这些贡献提高了团队效率和患者护理。学生药剂师认可了这些贡献,他们的经验成为跨专业实践的典范。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信